logo

For the Inventor, By the Inventor

North Chicago, IL, United States of America

Abbvie Stemcentrx LLC


USPTO Granted Patents = 40



Forward Citations = 144

Loading Chart...
Loading Chart...

43 inventors (with patents filed for the assignee):

goldMedal Scott J Dylla (28 out of 50 patents)

silverMedal David Y Liu (26 out of 108 patents)

bronzeMedal Orit Foord (25 out of 78 patents)

4.  Robert A Stull (25 out of 44 patents)

5.  Laura Saunders (24 out of 38 patents)

6.  Michael Torgov (19 out of 49 patents)

7.  Hui Shao (17 out of 36 patents)

8.  Alex Bankovich (4 out of 5 patents)

9.  Johannes Hampl (4 out of 5 patents)

10.  Marianne Theresa Santaguida (3 out of 7 patents)

11.  Samuel Williams (3 out of 3 patents)

12.  Mandy Boontanrart (3 out of 3 patents)

13.  Monette Aujay (3 out of 5 patents)

14.  Wade C Anderson (3 out of 4 patents)

15.  Deepti Rokkam (3 out of 18 patents)


Core Competencies:
Antibody Drug Conjugates
Anti-DLL3 Antibodies
Monoclonal Antibodies
Light Chain Variable Regions
Cell Subpopulations
Modulators
Site-Specific Conjugation
Anti-PTK7 Antibodies
Anti-BMPR1B Antibodies
Anti-DPEP3 Antibodies
Multispecific Constructs
Anti-SEZ6 Antibodies

40 patents:

1. 11077203 - Anti-SEZ6 antibody drug conjugates and methods of use (2021-08-03),
2. 11033634 - Light chain variable regions (2021-06-15),
3. 10934359 - Anti-BMPR1B antibodies and methods of use (2021-03-02),
4. 10836831 - Anti-PTK7 antibodies and methods of use (2020-11-17),
5. 10533051 - Anti SEZ6 antibodies and methods of use (2020-01-14),
6. 10478509 - Anti-DLL3 antibody drug conjugates for treating cancer (2019-11-19),
7. 10428156 - Anti-MFI2 antibodies and methods of use (2019-10-01),
8. 10308721 - Anti-DLL3 antibodies and drug conjugates for use in melanoma (2019-06-04),
9. 10189910 - Anti-DPEP3 antibodies and methods of use (2019-01-29),
10. 10137204 - Anti-DLL3 antibody drug conjugates for treating cancer (2018-11-27),
11. 10087258 - Anti-CD324 monoclonal antibodies and uses thereof (2018-10-02),
12. 10053511 - Anti-claudin antibodies and methods of use (2018-08-21),
13. 10047163 - Multispecific constructs (2018-08-14),
14. 10035853 - Site-specific antibody conjugation methods and compositions (2018-07-31),
15. 10017565 - Modulators and methods of use (2018-07-10),
AbbVie Stemcentrx LLC is a biotechnology company focused on discovering and developing innovative oncology treatments. They use a proprietary platform to identify and target cancer stem cells, aiming to revolutionize cancer treatment and improve patient outcomes.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
40 Patents

#4 in North Chicago, IL

#461 in Illinois

#8,351 in US

#16,570 in the World

...
North Chicago, IL, United States of America

Abbvie Stemcentrx LLC

Forward Citations = 144

43 inventors:

goldMedal Scott J Dylla (28 out of 50 patents)

silverMedal David Y Liu (26 out of 108 patents)

bronzeMedal Orit Foord (25 out of 78 patents)

4.  Robert A Stull (25 out of 44 patents)

5.  Laura Saunders (24 out of 38 patents)

Please report any incorrect information to support@idiyas.com
Loading…